OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targets, trials and tribulations in Alzheimer therapeutics
Ruchita Gharat, Gargi Dixit, Mihir Khambete, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176230-176230
Closed Access | Times Cited: 7
Ruchita Gharat, Gargi Dixit, Mihir Khambete, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176230-176230
Closed Access | Times Cited: 7
Showing 7 citing articles:
A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer’s Disease
Dinah V. Parums
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 9
Dinah V. Parums
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 9
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
ARMAN YURISALDI SALEH, Dwi Arwandi Yogi Saputra, Riezky Valentina, et al.
F1000Research (2025) Vol. 14, pp. 275-275
Open Access
ARMAN YURISALDI SALEH, Dwi Arwandi Yogi Saputra, Riezky Valentina, et al.
F1000Research (2025) Vol. 14, pp. 275-275
Open Access
Opposing roles of physiological and pathological amyloid-β on synapses in live human brain slice cultures
Robert I. McGeachan, S. Meftah, Lewis W. Taylor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Robert I. McGeachan, S. Meftah, Lewis W. Taylor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
From Plaques to Pathways in Alzheimer’s Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis
Sarah Kazemeini, Ahmed Nadeem-Tariq, Ryan M. Shih, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11720-11720
Open Access | Times Cited: 2
Sarah Kazemeini, Ahmed Nadeem-Tariq, Ryan M. Shih, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11720-11720
Open Access | Times Cited: 2
The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review
Juliette Foucher, Louisa Azizi, Linn Öijerstedt, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Juliette Foucher, Louisa Azizi, Linn Öijerstedt, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Advances in natural polysaccharides in Alzheimer's disease and Parkinson's disease: Insights from the brain-gut axis
Yueqin Feng, Fengjin Hao
Trends in Food Science & Technology (2024) Vol. 153, pp. 104678-104678
Closed Access | Times Cited: 1
Yueqin Feng, Fengjin Hao
Trends in Food Science & Technology (2024) Vol. 153, pp. 104678-104678
Closed Access | Times Cited: 1
Synthesis and pharmacological characterization of UVI3502, a novel cannabinoid receptor 1 (CB1) antagonist/inverse agonist
Iker Bengoetxea de Tena, Gorka Pereira‐Castelo, Jonatan Martínez‐Gardeazabal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Iker Bengoetxea de Tena, Gorka Pereira‐Castelo, Jonatan Martínez‐Gardeazabal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
